GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Other Income (Expense)

Firebrick Pharma (ASX:FRE) Other Income (Expense) : A$2.90 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Other Income (Expense)?

Firebrick Pharma's other income expense for the Firebrick Pharma's pretax income for the six months ended in Dec. 2024 was A$0.17 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$2.90 Mil.

Firebrick Pharma Other Income (Expense) Historical Data

The historical data trend for Firebrick Pharma's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Other Income (Expense) Chart

Firebrick Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Other Income (Expense)
- 1.08 0.02 2.74

Firebrick Pharma Semi-Annual Data
Jun21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Income (Expense) Get a 7-Day Free Trial - 0.02 - 2.74 0.17

Firebrick Pharma Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$2.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Firebrick Pharma  (ASX:FRE) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Firebrick Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Other Income (Expense)
Comparable Companies
ASX:ECS ASX:PER ASX:IVX ASX:EOF ASX:AGH ASX:NXS ASX:CAN ASX:RGT ASX:EXL ASX:BP8 LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN MRK AMGN GILD
Traded in Other Exchanges
N/A
Address
440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000
Website
https://www.firebrickpharma.com
Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand. Its Nasodine Nasal Spray which is in the commercialization phase, is a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. In parallel, the company is also engaged in the development of the follow-on Nasodine brand products.

Firebrick Pharma Headlines

No Headlines